2cureX AB (2CUREX) - Cash Flow Conversion Efficiency

Latest as of June 2025: 3.288x

Based on the latest financial reports, 2cureX AB (2CUREX) has a cash flow conversion efficiency ratio of 3.288x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr2.06 Million ≈ $221.47K USD) by net assets (Skr626.00K ≈ $67.37K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 2cureX AB defensive interval ratio to measure how many days the company can operate on defensive assets alone.

2cureX AB - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how 2cureX AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

2cureX AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of 2cureX AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Mangoceuticals, Inc. Common Stock NASDAQ:MGRX	-0.079x
Nexgel Inc NASDAQ:NXGL	-0.112x
Alaunos Therapeutics Inc NASDAQ:TCRT	-0.256x
European Opportunities Trust plc LSE:EOT	-0.002x
YGL Convergence Bhd KLSE:0086	0.001x
ScandiDos AB ST:SDOS	0.015x
GRAND PEAK CAPITAL F:6GP1	-0.012x
Willow Biosciences Inc TO:WLLW	0.055x

Annual Cash Flow Conversion Efficiency for 2cureX AB (2015–2024)

The table below shows the annual cash flow conversion efficiency of 2cureX AB from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of 2cureX AB.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr5.10 Million ≈ $548.73K	Skr-4.63 Million ≈ $-497.83K	-0.907x	+64.90%
2023-12-31	Skr12.08 Million ≈ $1.30 Million	Skr-31.22 Million ≈ $-3.36 Million	-2.585x	-297.53%
2022-12-31	Skr43.03 Million ≈ $4.63 Million	Skr-27.98 Million ≈ $-3.01 Million	-0.650x	-162.37%
2021-12-31	Skr74.34 Million ≈ $8.00 Million	Skr-18.43 Million ≈ $-1.98 Million	-0.248x	-24.76%
2020-12-31	Skr58.86 Million ≈ $6.33 Million	Skr-11.69 Million ≈ $-1.26 Million	-0.199x	+29.07%
2019-12-31	Skr28.08 Million ≈ $3.02 Million	Skr-7.86 Million ≈ $-846.29K	-0.280x	-431.76%
2018-12-31	Skr13.62 Million ≈ $1.47 Million	Skr1.15 Million ≈ $123.76K	0.084x	+139.30%
2017-12-31	Skr20.24 Million ≈ $2.18 Million	Skr-4.35 Million ≈ $-467.91K	-0.215x	-240.95%
2016-12-31	Skr7.91 Million ≈ $851.78K	Skr1.21 Million ≈ $129.84K	0.152x	+160.87%
2015-12-31	Skr8.19 Million ≈ $881.25K	Skr-2.05 Million ≈ $-220.70K	-0.250x	--

About 2cureX AB

ST:2CUREX Sweden Biotechnology

Market Cap

$5.16 Million

Skr47.95 Million SEK

Market Cap Rank

#28510 Global

#647 in Sweden

Share Price

Skr1.91

Change (1 day)

-4.98%

52-Week Range

Skr0.51 - Skr4.00

All Time High

Skr28.20